Ira Jacobson

NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome.

Stefan Zeuzem, Steven Knox, A. Mangia, 2017, Journal of hepatology.

Recent progress in the development of selected hepatitis C virus NS3.4A protease and NS5B polymerase inhibitors.

A. Kwong, I. Jacobson, Ira Jacobson, 2008, Current opinion in pharmacology.

Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial.

Thomas Berg, Stefan Zeuzem, Oliver Lenz, 2014, Gastroenterology.